Target intelligence / Profile preview

Keratin 18 pseudogene 63 (KRT18P63)

Target: KRT18P63
Molecular classification: Other (pseudogene)

Overview

Keratin 18 pseudogene 63 (KRT18P63) is classified as a human pseudogene related to the keratin 18 gene family. Pseudogenes are stretches of DNA that resemble functional genes but contain mutations, deletions, or insertions that render them nonfunctional for protein coding. There is no evidence that KRT18P63 expresses a functional product or is involved in any biological process, disease, or therapeutic targeting. Any research or clinical role attributed to the parent gene (KRT18) does not extend to this pseudogene. If you intended to inquire about Keratin 18 (KRT18), which encodes a functional intermediate filament protein significant in epithelial biology and disease, please clarify, as the biological and disease roles are very different.

Other names: KRT18P63keratin 18 pseudogene 63

Mechanism of action

Not applicable (pseudogene; no protein product or targeting mechanism).

Biological functions

None established for the pseudogene itself. The parent gene, Keratin 18 (KRT18), encodes a major cytoskeletal intermediate filament protein in epithelial cells, but pseudogenes generally lack direct biological function unless proven otherwise.

Disease associations

None established for the pseudogene. The parent gene, Keratin 18, is implicated in some liver diseases and cancer biology, but this does not generally apply to its pseudogenes.

Safety considerations

Not applicable. There are no therapeutic or diagnostic interventions involving KRT18P63.

Interacting drugs

None known. No drugs are known to interact with KRT18P63.

Biomarkers

None established for the pseudogene. Keratin 18 protein is used as a biomarker in certain diseases (e.g., epithelial tumors, liver disease), but this does not apply to its pseudogenes.

Beyond the preview

Go deeper on Keratin 18 pseudogene 63 (KRT18P63).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 18 pseudogene 63 (KRT18P63).

Explore the full profile